Franck Atienzar's Biography

Franck Atienzar, Head/Associate Director, UCB Pharma SA

Franck Atienzar obtained his PhD in Environmental Toxicology at the University of Plymouth(UK) in 2000. After a short experience at Sigma -Aldrich (technical Service: molecular biology specialist, France), he joined UCB-Pharma in 2002 as Head of the In Vitro Toxicology Unit. His objectives are to implement strategies and technologies (measure of gene expression, hepatotoxic, genotoxic and cytotoxic markers, detection of phospholipidosis, ....) in the context of early toxicological assessment of pharmaceutical compounds. Franck, who also works for the European commission as an independent expert, evaluates scientific projects submitted for European funding. So far, he has published part of his work in 4 book chapters and in 23 peer-reviewed journals.

Which Models to Use in Early Toxicology Assessment to Detect Human Hepatotoxic Drugs?

Thursday, 11 April 2013 at 14:15

Add to Calendar ▼2013-04-11 14:15:002013-04-11 15:15:00Europe/LondonWhich Models to Use in Early Toxicology Assessment to Detect Human Hepatotoxic Drugs?ADME and Predictive Toxicology in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com

One of our objectives was also to study the Crabtree effect particularly for the detection of mitochondrial toxicity. An overview of the different approaches will be presented in terms of predictivity (i.e. sensitivity and specificity) . Finally, a summary of the most promising studies from the literature will be also presented.

Add to Calendar ▼2013-04-11 00:00:002013-04-12 00:00:00Europe/LondonADME and Predictive ToxicologyADME and Predictive Toxicology in Barcelona, SpainBarcelona, SpainSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors